Evaluation of laser efficacy in treatment of cutaneous leishmaniasis lesio
Not Applicable
- Conditions
- Cutaneous Leishmaniasis.Cutaneous Leishmaniasis
- Registration Number
- IRCT201404303862N12
- Lead Sponsor
- Mashhad University of Medical Sciences, Vice Chancellor for Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
age more than 12 years old; informed consent of patient for participating in study; atrophic scar in hand or face with duration of improvement more than one year
Exclusion criteria: patients with chronic disease like diabetes and collagen vascular diseases that have a problem in scar healing; hypertrophic or keloid scars; history for receiving isotretinoin during last year; pregnancy or breastfeeding; immunodeficiency patients like patients under immunosuppressive medicines; patients who don’t complete treatment period or don’t refer for follow ups; skin type VI; history of radiotherapy in laser locations; patients with positive coiner disease like psoriasis and vitiligo
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete healing. Timepoint: For the first before intervention, then during therapy sessions, and 3 and 6 months after the last treatment session. Method of measurement: Measuring the size of induration and scar.
- Secondary Outcome Measures
Name Time Method Side effects including erythema, edema, petechiae, dispigmentation and scar. Timepoint: start of therapy, 3 and 6 months after the last treatment session. Method of measurement: Physical exam.